Activation of the Aryl Hydrocarbon Receptor by TCDD Inhibits Mammary Tumor Metastasis in a Syngeneic Mouse Model of Breast Cancer

Treatment with aryl hydrocarbon receptor (AhR) agonists can slow or reverse the growth of primary mammary tumors in rodents, which has fostered interest in developing selective AhR modulators for treatment of breast cancer. However, the major goal of breast cancer therapy is to inhibit metastasis, t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Tao, Wyrick, Katie L., Meadows, Gary G., Wills, Tamara B., Vorderstrasse, Beth A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2011
Konular:
Carcinogenicity
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216416/
https://ncbi.nlm.nih.gov/pubmed/21948867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxsci/kfr247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller